Corcept Therapeutics Incorporated (CORT)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.50-0.14 (-2.48%)
At close: 4:00 PM EDT
People also watch:
CYTKCRISGTXICYCCDVAX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open5.64
Prev Close5.64
Bid5.40 x 200
Ask6.10 x 400
Day's Range5.49 - 5.82
52wk Range3.22 - 6.33
1y Target EstN/A
Market Cap608.27M
P/E Ratio (ttm)611.11
Beta1.47
Volume204,401
Avg Vol (3m)383,434
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETF’s with exposure to Corcept Therapeutics, Inc. : August 22, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Corcept Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to CORT-US. Comparing the performance and risk of Corcept Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
    Zacks3 days ago

    Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults

    Supernus Pharmaceuticals, Inc. (SUPN) announced that the FDA has granted a tentative approval to the company's sNDA for a label expansion for Trokendi XR to include prophylaxis of migraine headache in adults.

  • What Falling Estimates & Price Mean for Merus Labs International (MSLI)
    Zacks3 days ago

    What Falling Estimates & Price Mean for Merus Labs International (MSLI)

    One such stock that you may want to consider dropping is Merus Labs International Inc. (MSLI), which has witnessed a significant price decline in the past four weeks